Key Takeaways
- Hiring commercial leadership too early creates cost; hiring too late leaves critical decisions without commercial judgment.
- Commercial decisions begin before the commercial department exists.
- The first commercial leader must operate across strategy, launch, access, organization and board communication.
- Hire for the company’s next stage—not to recreate a large pharmaceutical leadership team.
Hiring commercial leadership too early can create unnecessary cost. Hiring too late can result in commercial decisions being made without commercial leadership.
The correct timing depends upon the asset, market, organization and strategic direction.
The key question is not simply how many months before launch a Chief Commercial Officer should be hired. The better question is: when do the decisions being made by the company require experienced commercial leadership?
What Should Trigger the Commercial Leadership Decision?
The decision to hire senior commercial leadership should not be governed by a universal countdown to launch.
A more useful trigger is the nature of the decisions the company is beginning to make.
Experienced commercial leadership becomes increasingly important when the company must make decisions involving:
- commercial opportunity and indication prioritization
- commercialization versus partnering
- organizational design
- launch investment
- market access
- product positioning
- evidence strategy
- commercial hiring
- field model design
- patient services
- launch governance
- board communication about commercial readiness
If these decisions are already being made, the question is no longer whether the commercial organization formally exists. The question is whether the company has appropriate commercial judgment at the table.
Full-Time, Fractional or External Advisory?
Not every emerging biotechnology company requires a full commercial executive at the same development stage.
Depending on the asset, financing position, development timeline and strategic alternatives, companies may initially use external senior commercial advisory before committing to a permanent commercial leadership structure.
External advisory can help leadership pressure-test commercial assumptions, define what capabilities will eventually be required and determine when permanent leadership becomes necessary.
As commercialization becomes operational rather than primarily strategic, internal ownership becomes increasingly important.
The objective should be to build capability at the point it creates value—not according to a generic organizational template.
The First Commercial Leader Has a Different Job
The first commercial executive in an emerging biotechnology company is not simply managing an established marketing or sales organization.
The role may require simultaneously defining strategy, challenging market assumptions, designing the organization, recruiting leaders, aligning Medical Affairs and Market Access, communicating with the board and creating an execution system where none existed previously.
That requires a broader leadership profile than operating a mature commercial function.
Related: commercial leadership, biotech commercial strategy, first commercial launch, launch readiness assessment and commercial readiness framework.
Making the First Commercial Leadership Decision?
PharmaKonsult provides senior commercial perspective to biotechnology leadership teams evaluating organizational design, leadership requirements and commercialization readiness.
Executive opinion paper
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.
About Joseph McCoy
Joseph McCoy is Founder and Principal Consultant of PharmaKonsult and an executive commercial strategy advisor with more than three decades of pharmaceutical and biotechnology commercial leadership experience across neuroscience, rare disease, endocrinology, institutional healthcare and specialty pharmaceuticals.
